new oral glp 1 agonist GLP-1 Agonists: A Comprehensive Overview With FDA approval of Wegovy
Description
doi:10.1016/j.cct.2023.107176 204
Equity concerns remain because those with wealth or insurance get rapid access, while others wait
The medical goal is bigger than a number
Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: A prospective randomized clinical trial using magnetic resonance imaging and spectroscopy
The decision to continue, taper, or stop should be individualized, not driven by arbitrary timelines
